So proud, best presentation at IMAD2024! Joachim Sejr Skovbo Kristensen, MD, PhD student, took the first prize at this years IMAD symposium! He presented our surprising observation that the growth rate of AAA is half in AAA of The DANCAVAS trial compared to the VIVA AAA screening cohort. Smoking was similar, a bit more were diabetic, BMI was equal, - the only reason we can guess of is the prescriped statin was 40 mg of atorvastatin in the DANCAVAS trial compared to 40 mg Simvastin in the VIVA trial. An advanced Pharmacoepdiomogical registry study exploiting the unique access to the Danish nationwide registries is being set up for clarification.
Kæmpestort tillykke, Joachim 👏
Yes congrats to Joachim and his very nice data well presented and the price so well deserved🍾🇩🇰
Flot, Joachim! 👏
Stærkt, Joachim! 😃
Tillykke Joachim! Så flot! 👏😃
Adjungerad Professor på Karolinska institutet
4moWell deserved, from a great research group!